Barkana BD, El-Sayed A, Khaled RH, Helal M, Khaled H, Deeb R et al (2022) Imaging modalities in inflammatory breast cancer (IBC) diagnosis: a computer-aided diagnosis system using bilateral mammography images. Sensors 23(1):64

Article  PubMed  PubMed Central  Google Scholar 

Cserni G, Charafe-Jauffret E, Van Diest PJ (2018) Inflammatory breast cancer: the pathologists’ perspective. Eur J Surg Oncol 44(8):1128–1134

Article  CAS  PubMed  Google Scholar 

Fouad TM, Barrera AMG, Reuben JM, Lucci A, Woodward WA, Stauder MC et al (2017) Inflammatory breast cancer: a proposed conceptual shift in the UICC–AJCC TNM staging system. Lancet Oncol 18(4):e228–e232

Article  PubMed  PubMed Central  Google Scholar 

Girardi V, Carbognin G, Camera L et al (2011) Inflammatory breast carcinoma and locally advanced breast carcinoma: characterisation with MR imaging. Radiol Med 116(1):71–83

Article  CAS  PubMed  Google Scholar 

Resetkova E (2008) Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosis. Semin Oncol 35(1):25–32

Article  PubMed  Google Scholar 

Jiao D, Zhang J, Zhu J, Guo X, Yang Y, Xiao H et al (2021) Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis. BMC Cancer 21(1):138

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brzezinska M, Dixon JM (2018) Inflammatory breast cancer: no longer an absolute contraindication for breast conservation surgery following good response to neoadjuvant therapy. Gland Surg 7(6):520–524

Article  PubMed  PubMed Central  Google Scholar 

Dabi Y, Darrigues L, Pons K, Mabille M, Abd Alsamad I, Mitri R et al (2017) Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms. Ahmad A, editor. PLoS ONE 12(12):e0189385

Wecsler JS, Tereffe W, Pedersen RC, Sieffert MR, Mack WJ, Cui H et al (2015) Lymph node status in inflammatory breast cancer. Breast Cancer Res Treat 151:113e20

Sobin L, Ch Wittekind (eds) (2002) UICC TNM classification of malignant tumours, 6th edn. Wiley-Liss, New York

Sobin L, Gospodarowicz M, Ch Wittekind (eds) (2009) UICC TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Chichester

van Uden DJP, van Laarhoven HWM, Westenberg AH, de Wilt JHW, Blanken- Peeters CFJM (2015) Inflammatory breast cancer: an overview. Crit Rev Oncol Hematol 93:116e26

Garrido-Castro AC, Regan MM, Niman SM, Nakhlis F, Remolano C, Rosenbluth JM et al (2023) Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer. npj Breast Cancer 9(1):50

Wang Z, Chen M, Pan J, Wang X, Chen XS, Shen KW (2020) Pattern of distant metastases in inflammatory breast cancer - a large-cohort retrospective study. J Cancer 11(2):292–300

Article  PubMed  PubMed Central  Google Scholar 

Yamauchi H, Woodward WA, Valero V, Alvarez RH, Lucci A, Buchholz TA et al (2012) Inflammatory breast cancer: what we know and what we need to learn. Oncologist 17(7):891–899

Article  PubMed  PubMed Central  Google Scholar 

Stearns V, Ewing CA, Slack R et al (2002) Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9:235–242

Article  PubMed  Google Scholar 

Jagsi R, Mason G, Overmoyer BA, Woodward WA, Badve S, Schneider RJ et al (2022) Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research. Breast Cancer Res Treat 192(2):235–243

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vagia E, Cristofanilli M (2021) New treatment strategies for the inflammatory breast cancer. Curr Treat Options in Oncol 22(6):50

Article  Google Scholar 

Parton M, Dowsett M, Ashley S, Hills M, Lowe F, Smith IE (2004) High incidence of HER-2 positivity in inflammatory breast cancer. Breast 13(2):97–103

Article  CAS  PubMed  Google Scholar 

Lê MG, Arriagada R, Contesso G, Cammoun M, Pfeiffer F, Tabbane F, Bahi J, Dilaj M, Spielmann M, Travagli JP, Tursz T, Mourali N (2005) Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patients. Clin Breast Cancer 6(5):439–445

Article  PubMed  Google Scholar 

Valente SA, ElSherif A, Tran J, Tu C, Kruse M (2023) Inflammatory breast cancer and the importance of skin punch biopsy. Am J Surg 225(3):549–552

Article  PubMed  Google Scholar 

Le-Petross HT, Balema W, Woodward WA (2021) Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges: a narrative review. Chin Clin Oncol 10(6):58–58

Article  PubMed  Google Scholar 

Curigliano G (2018) Inflammatory breast cancer and chest wall disease: the oncologist perspective. Eur J Surg Oncol 44(8):1142–1147

Article  PubMed  Google Scholar 

Abraham HG, Xia Y, Mukherjee B, Merajver SD (2021) Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database. Breast Cancer Res Treat 185(1):229–238

Article  PubMed  Google Scholar 

Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F et al (2018) International consensus on the clinical management of inflammatory breast cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer 9(8):1437–1447

Article  PubMed  PubMed Central  Google Scholar 

Alunni JP (2012) Imaging inflammatory breast cancer. Diagn Interv Imaging 93(2):95–103

Article  PubMed  Google Scholar 

Günhan-Bilgen I, Ustün EE, Memiş A (2002) Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology 223(3):829–838

Article  PubMed  Google Scholar 

Hirko KA, Soliman AS, Banerjee M, Ruterbusch J, Harford JB, Merajver SD et al (2014) A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007–2009. Breast J 20(2):185–191

Article  PubMed  Google Scholar 

Sosa A, Lei X, Woodward WA, Chavez Mac Gregor M, Lucci A, Giordano SH et al (2022) Trends in sentinel lymph node biopsies in patients with inflammatory breast cancer in the US. JAMA Netw Open 5(2):e2148021

Xu F, Yang J, Han D, Huang Q, Li C, Zheng S et al (2021) Nomograms for estimating cause-specific death rates of patients with inflammatory breast cancer: a competing-risks analysis. Technol Cancer Res Treat 1(20):153303382110163

Article  Google Scholar 

Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST et al (2016) Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer. Cancer Epidemiol 40:7–14

Article  PubMed  Google Scholar 

Schairer C, Hablas A, Eldein IAS, Gaafar R, Rais H, Mezlini A et al (2019) Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa. Breast Cancer Res Treat 176(2):407–417

Article  PubMed  PubMed Central  Google Scholar 

Van Berckelaer C, Rypens C, Van Dam P, Pouillon L, Parizel M, Schats KA et al (2019) Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression. Breast Cancer Res 21(1):28

Article  PubMed  PubMed Central  Google Scholar 

Dawood S, Ueno NT, Valero V, Woodward WA, Buchholz TA, Hortobagyi GN et al (2011) Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study. Cancer 117(9):1819–1826

Article  PubMed  Google Scholar 

Kumar N, Sayed S, Moloo Z, Wasike R (2011) Fine-needle aspiration in suspected inflammatory breast cancer: case series with emphasis on approach to specimen adequacy. Acta Cytol 55(3):239–244

Article  PubMed  Google Scholar 

Chainitikun S, Espinosa Fernandez JR, Long JP, Iwase T, Kida K, Wang X et al (2021) Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: a systematic review. Gupta S, editor. PLoS ONE 16(4):e0250057

Selvarajan G, Radhakrishnan V, Jayachandran PK, SubramaniamMurali C, Velusamy S, Krishnamurthy A et al (2022) Forecasting factors and outcomes in hawkish inflammatory breast carcinoma - a single center data exploration. Cancer Treat Res Commun 32:100599

Article  PubMed  Google Scholar 

Carkaci S, Adrada BE, Rohren E, Wei W, Quraishi MA, Mawlawi O et al (2012) Semiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer. Acad Radiol 19(5):535–541

Article  PubMed  PubMed Central  Google Scholar 

Li XJ, Zha QB, Xu XY, Xia L, Zhang Z, Ren ZJ et al (2014) Lack of prognostic value of human epidermal growth factor- like receptor 2 status in inflammatory breast cancer (IBC): a meta-analysis. Asian Pac J Cancer Prev 15(22):9615–9619

Article